Cardiac MR perfusion imaging: where we are

详细信息    查看全文

• 作者：Riccardo Marano (1)
  Luigi Natale (1)
  Amedeo Chiribiri (2)
  Federica Pirro (1)
  Valentina Silvestri (1)
  Giuseppe Coppola (1)
  Lorenzo Bonomo (1)
  
  1. Department of Radiological Sciences-Institute of Radiology ; Catholic University of Rome ; 鈥淎. Gemelli鈥?University Hospital ; L.go Agostino Gemelli 8 ; 00168 ; Rome ; Italy
  2. Department of Cardiovascular Imaging ; King鈥檚 College London ; The Rayne Institute ; St. Thomas鈥?Hospital ; London ; SE1 7EH ; UK
  
• 关键词：Cardiac magnetic resonance ; Perfusion imaging ; Ischaemia ; Coronary artery disease
• 刊名：La radiologia medica
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：120
• 期：2
• 页码：190-205
• 全文大小：1,542 KB
• 参考文献：1. Kim HW, Klem I, Kim RJ (2007) Detection of myocardial ischemia by stress perfusion cardiovascular magnetic resonance. Magn Reson Imaging Clin N Am 15:527鈥?40 CrossRef
  2. Araujo LI, Lammertsma AA, Rhodes CG et al (1991) Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen 15 labeled carbon dioxide inhalation and positron emission tomography. Circulation 83:875鈥?85 CrossRef
  3. Gould KL, Kirkeeide RL, Buchi M (1990) Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15:459鈥?74 CrossRef
  4. Gould K (1978) Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 41:267鈥?78 CrossRef
  5. Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461鈥?474 CrossRef
  6. Bartunek J, Sys SU, Heyndrickx GR et al (1995) Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol 26:328鈥?34 CrossRef
  7. Pijls NH, De Bruyne B, Peels K et al (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703鈥?708 CrossRef
  8. Atkinson DJ, Burstein D, Edelman RR (1990) First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 174:757鈥?62 CrossRef
  9. Manning WJ, Atkinson DJ, Grossman W et al (1991) First-pass nuclear magnetic resonance imaging using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18:959鈥?65 CrossRef
  10. Schwitter J, Nanz D, Kneifel S et al (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230鈥?235 CrossRef
  11. Schwitter J, Wacker CM, van Rossum AC et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480鈥?89 CrossRef
  12. Sakuma H, Suzawa N, Ichikawa Y et al (2005) Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 185:95鈥?02 CrossRef
  13. Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single-photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374鈥?79 CrossRef
  14. Greenwood JP, Maredia N, Younger JF et al (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453鈥?60 CrossRef
  15. Schwitter J, Wacker CM, Wilke N et al (2013) MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. MR-IMPACT Investigators. Eur Heart J 34:775鈥?81 CrossRef
  16. Jerosch-Herold M (2010) Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12:57 CrossRef
  17. Ishida M, Schuster A, Morton G et al (2011) Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:28 CrossRef
  18. Wilke N, Jerosch-Herold M, Wang Y et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373鈥?84 CrossRef
  19. Hundley WG, Bluemke DA, Finn JP et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121:2462鈥?508 CrossRef
  20. Di Cesare E, Cademartiri F, Carbone I et al (2013) Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging. Radiol Med 118:752鈥?98 CrossRef
  21. Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79:2鈥?0 CrossRef
  22. Hundley WG, Hamilton CA, Thomas MS et al (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697鈥?702 CrossRef
  23. Lanza GA, Buffon A, Sestito A et al (2008) Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 51:466鈥?72 CrossRef
  24. Iskandrian AE, Bateman TM, Belardinelli L et al (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645鈥?58 CrossRef
  25. Al Jaroudi W, Iskandrian AE (2009) Regadenoson: a new myocardial stress agent. J Am Coll Cardiol 54:1123鈥?1230 CrossRef
  26. Reyes E, Staehr P, Olmsted A et al (2011) Effect of body mass index on the efficacy, side effect profile, and plasma concentration of fixed-dose regadenoson for myocardial perfusion imaging. J Nucl Cardiol 18:620鈥?27 CrossRef
  27. Leaker BR, O鈥機onnor B, Hansel TT et al (2008) Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 15:329鈥?36 CrossRef
  28. Thomas GS, Tammelin BR, Schiffman GL et al (2008) Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (regcopd trial). J Nucl Cardiol 15:319鈥?28 CrossRef
  29. Zhao G, Messina E, Xu X et al (2007) Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist. J Cardiovasc Pharmacol 49:369鈥?75 CrossRef
  30. www.fda.gov [Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication鈥攔are but serious risk of heart attack and death (posted 20/11/2013])
  31. Kramer CM, Barkhausen J, Flamm SD et al (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35 CrossRef
  32. Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539鈥?42 CrossRef
  33. Klem I, Heitner JF, Shah DJ et al (2006) Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47:1630鈥?638 CrossRef
  34. Tsao J, Boesiger P, Pruessmann KP (2003) k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 50:1031鈥?042 CrossRef
  35. Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S (2007) Dynamic contrast- enhanced myocardial perfusion MRI accelerated with k-t SENSE. Magn Reson Med 58:777鈥?85 CrossRef
  36. Plein S, Schwitter J, Suerder D et al (2008) k-space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology 249:493鈥?00 CrossRef
  37. Lockie T, Ishida M, Perera D et al (2011) High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 57:70鈥?5 CrossRef
  38. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952鈥?62 CrossRef
  39. Cheng AS, Pegg TJ, Karamitsos TD et al (2007) Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 49:2440鈥?449 CrossRef
  40. Araoz PA, Glockner JF, McGee KP et al (2005) 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 7:559鈥?64 CrossRef
  41. Theisen D, Wintersperger BJ, Huber A et al (2007) Myocardial perfusion imaging with Gadobutrol: a comparison between 3 and 1.5 Tesla with an identical sequence design. Invest Radiol 42:499鈥?06 CrossRef
  42. Di Bella EVR, Parker DL, Sinusas AJ (2005) On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 54:1295鈥?299 CrossRef
  43. Morton G, Chiribiri A, Ishida M et al (2012) Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol 60:1546鈥?555 CrossRef
  44. Patel AR, Antkowiak PF, Nandalur KR et al (2010) Assessment of advanced coronary artery disease. J Am Coll Cardiol 56:561鈥?69 CrossRef
  45. Nandalur KR, Dwamena BA, Choudhri AF et al (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50:1343鈥?353 CrossRef
  46. Hamon M, Fau G, N茅e G et al (2010) Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 12:29 CrossRef
  47. de Jong MC, Genders TSS, van Geuns RG et al (2012) Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol 22:1881鈥?895 CrossRef
  48. Cury RC, Cattani CA, Gabure LA et al (2006) Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240:39鈥?5 CrossRef
  49. Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P (2008) Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. J Cardiovasc Magn Reson 10:8 CrossRef
  50. Rieber J, Huber A, Erhard I et al (2006) Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 27:1465鈥?471 CrossRef
  51. Kuhl HP, Katoh M, Buhr C et al (2007) Comparison of magnetic resonance perfusion imaging versus invasive fractional flow reserve for assessment of the hemodynamic significance of epicardial coronary artery stenosis. Am J Cardiol 99:1090鈥?095 CrossRef
  52. Costa MA, Shoemaker S, Futamatsu H et al (2007) Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 50:514鈥?22 CrossRef
  53. Ishida N, Sakuma H, Motoyasu M et al (2003) Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229:209鈥?16 CrossRef
  54. Paetsch I, Jahnke C, Wahl A et al (2004) Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110:835鈥?42 CrossRef
  55. Manka R, Jahnke C, Gebker R et al (2011) Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J Cardiovasc Imaging 27:995鈥?002 CrossRef
  56. Di Cesare E, Carbone I, Carriero A et al (2012) Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM). Radiol Med 117:901鈥?38 CrossRef
  57. Bettencourt N, Chiribiri A, Schuster A et al (2013) Direct comparison of cardiac magnetic resonance and multidetector computed tomography stress-rest perfusion imaging for detection of coronary artery disease. J Am Coll Cardiol 61:1099鈥?107 CrossRef
  58. Schuhb盲ck A, Marwan M, Cury RC et al (2013) Current status of cardiac CT for the detection of myocardial ischemia. Herz 38:359鈥?66 CrossRef
  59. Ingkanisorn WP, Kwong RY, Bohme NS et al (2006) Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 47:1427鈥?432 CrossRef
  60. Jahnke C, Nagel E, Gebker R et al (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769鈥?776 CrossRef
  61. Pilz G, Jeskea A, Klos M et al (2008) Prognostic value of normal adenosine stress cardiac magnetic resonance imaging. Am J Cardiol 101:1408鈥?412 CrossRef
  62. Lubbers DD, Rijlaarsdam-Hermsen D, Kuijpers D et al (2012) Performance of adenosine 鈥渟tress-only鈥?perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study. Int J Cardiovasc Imaging 28:109鈥?15 CrossRef
  63. Nagel E, Klein C, Paetsch I et al (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108:432鈥?37 CrossRef
  64. Takase B, Nagata M, Kihara T et al (2004) Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J 45:475鈥?86 CrossRef
  65. Plein S, Radjenovic A, Ridgway JP et al (2005) Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 235:423鈥?30 CrossRef
  66. Pilz G, Bernhardt P, Klos M et al (2006) Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 95:531鈥?38 CrossRef
  67. Greenwood JP, Younger JF, Ridgway JP et al (2007) Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 93:1363鈥?368 CrossRef
  68. Seeger A, Doesch C, Klumpp B et al (2007) MR stress perfusion for the detection of flow-limiting stenoses in symptomatic patients with known coronary artery disease and history of stent implantation. Rofo 179:1068鈥?073 CrossRef
  69. Giang TH, Nanz D, Coulden R et al (2004) Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 25:1657鈥?665 CrossRef
  70. Wolff SD, Schwitter J, Coulden R et al (2004) Myocardial first pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 110:732鈥?37 CrossRef
  
• 刊物主题：Imaging / Radiology; Diagnostic Radiology; Interventional Radiology; Neuroradiology; Ultrasound;
• 出版者：Springer Milan
• ISSN：1826-6983

文摘

To date, several clinical and multicentre studies have demonstrated the accuracy of perfusion cardiac magnetic resonance to detect ischaemia in comparison with quantitative coronary angiography, other noninvasive diagnostic techniques (single photon emission computed tomography; positron-emission tomography), and invasive haemodynamic measurements (fractional flow reserve). Moreover, the favourable safety profile and increasing availability contribute to make perfusion cardiac magnetic resonance one of the modalities of choice for the detection of myocardial ischaemia. Recently, the first evidence of the prognostic value of perfusion cardiac magnetic resonance results has also become available. This review summarises the technical and interpretation key points of perfusion cardiac magnetic resonance scan, the clinical indications, the most recent available literature about its diagnostic performance and prognostic value, and how perfusion cardiac magnetic resonance compares with other noninvasive techniques.